https://www.thebodypro.com/category/prep-hiv-pre-exposure-prophylasxis/tag/sexually-transmitted-infections
PrEP (HIV Pre-Exposure Prophylaxis)

Sexually Transmitted Infections

The Latest

doctor patient hands

This Week in HIV Research: Health in Unity

Jan. 21, 2021: Dyad-level interventions in serodiscordant relationships; using social media to improve PrEP uptake; HCV prevalence among MSM; the irrelevance of doxycycline prophylaxis against mycoplasma genitalium.

By Barbara Jungwirth and Myles Helfand
Promo Image

This Week in HIV Research: Our Immensely Intersectional Epidemic

Dec. 3, 2020: A simple scoring system for PrEP referral; integrating meth use and HIV prevention interventions; genetically linked HIV strains cross county lines; viral suppression rates in first vs. second pregnancies.

By Barbara Jungwirth and Myles Helfand
chlamydia

DoxyPEP for STIs: Are We Ready for Prophylactic Doxycycline for MSM on HIV PrEP?

A recent expert debate explored the pros and cons of prescribing the antibiotic as a preventive measure for a subset of people at especially high risk for sexually transmitted infections.

By Michael Broder
brain dissipation

This Week in HIV Research: What We Don’t Know Hurts Them

Aug. 20, 2020: HIV knowledge and stigma among health care workers in the southern U.S.; condomless sex vs. HIV risk among MSM; how drug class choice may affect onward transmission risk; STI screening rates among MSM on PrEP.

By Barbara Jungwirth and Myles Helfand
links in chain

This Week in HIV Research: Links in a Chain

July 16, 2020: Starting HIV treatment during hospitalization for people who use drugs; type of substance use affects viral suppression odds; benefits of a cross-disciplinary medical support team; does STI recency dictate PrEP necessity for women?

By Barbara Jungwirth and Myles Helfand
long road ahead

This Week in HIV Research: Do As We Say, Not As We Do

July 9, 2020: Abysmal HIV testing rates in U.S. ambulatory care settings; STI testing frequency in PrEP users; trends in U.S. PrEP uptake; integrating opioid therapy with HCV care in people who inject drugs.

By Barbara Jungwirth and Myles Helfand
integrase inhibitor

This Week in HIV Research: The Fast-Acting Power of Integrase

April 9, 2020: Rapid efficacy of integrase-based treatment; a potent PrEP ad campaign in Chicago; more frequent STI screening for PrEP users; Ryan White funding fuels critical rural HIV care and services.

By Barbara Jungwirth and Myles Helfand
Johanne Morne and Dr. Oni Blackstock

Ending the HIV Epidemic Is a Team Effort. The New York City and State Health Departments Discuss Their Combined Work

Johanne Morne, M.S., and Oni Blackstock, M.D., sat down with TheBody to discuss their successes and their work to close the disparities gap.

By Terri Wilder, M.S.W.
grindr screens

Grindr Users Take PrEP More and Have Lower HIV Rates, but Have Higher Rate of STIs Than Men Not on the App

Gay and bisexual men who used Grindr were having more sex acts associated with increased risk, but were more likely to use PrEP or be open to it, which translated to lower HIV incidence.

By Kenyon Farrow
Young people walking with the Lincoln Memorial in the background

Washington, D.C. Youth Face Barriers to HIV Prevention and Sexual Health

Young people in the nation's capital are living in the middle of some of the worst structural and systemic inequalities in America. We should be helping them out.

By Chase Alston